DBV Technologies (DBVT) Accounts Payables (2015 - 2026)

DBV Technologies (DBVT) posted quarterly Accounts Payables of $39.4 million for Q2 2026, down 3.41% year-on-year from $40.8 million in Q2 2025, and little changed on a QoQ basis from $39.5 million in Q1 2026.

DBV Technologies (DBVT) Accounts Payables (2015 - 2026) Analysis & Trends

DBV Technologies (DBVT) has reported Accounts Payables for 12 consecutive years, with $39.4 million the latest figure, recorded in Q2 2026.

  • Quarterly Accounts Payables fell 3.41% year-over-year to $39.4 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $39.4 million (down 3.41% YoY) and the FY2025 annual result came in at $40.9 million, up 85.64% from the prior year.
  • Accounts Payables steadied at $39.4 million in Q2 2026 per DBVT's latest filing, from $39.5 million in the prior quarter.
  • Over the last five years, Accounts Payables for DBVT reached as high as $40.9 million in Q4 2025 and fell as low as $11.4 million in Q1 2022.
  • A 5-year average of $25.2 million and a median of $21.0 million in 2023 frame the typical range for Accounts Payables.
  • Annual changes were most pronounced in 2022 — Accounts Payables slumped 33.54% — and 2025, when it jumped 105.83%.
  • Year by year, Accounts Payables stood at $14.5 million in 2022, then soared by 61.0% to $23.3 million in 2023, then fell by 5.45% to $22.0 million in 2024, then jumped by 85.64% to $40.9 million in 2025, then slipped by 3.67% to $39.4 million in 2026.
  • According to Business Quant data, Accounts Payables over the past three periods registered $39.4 million, $39.5 million, and $40.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 5.74 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 10.62 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 423.55 Mn
4 NuCana 279.75 Bn 279.75 Bn - 694,346.76
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 489.30 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 1.03 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.52 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 80.54 Mn
10 DBV Technologies 267.50 Mn 92.60 Mn - 39.40 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 39.40 Mn
Mar 31, 2026 39.50 Mn
Dec 31, 2025 40.90 Mn
Sep 30, 2025 39.82 Mn
Jun 30, 2025 40.79 Mn
Mar 31, 2025 34.15 Mn
Dec 31, 2024 22.03 Mn
Sep 30, 2024 22.50 Mn
Jun 30, 2024 19.82 Mn
Mar 31, 2024 18.08 Mn
Dec 31, 2023 23.30 Mn
Sep 30, 2023 16.65 Mn
Jun 30, 2023 19.09 Mn
Mar 31, 2023 19.94 Mn
Dec 31, 2022 14.47 Mn
Sep 30, 2022 15.37 Mn
Jun 30, 2022 16.34 Mn
Mar 31, 2022 11.42 Mn
Dec 31, 2021 11.43 Mn
Sep 30, 2021 12.17 Mn